Carolina Velazquez
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe.
Journal: Cancer research
Published: April 27, 2024
CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer.
Journal: Cancer letters
Published: October 06, 2023
BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib.
Journal: Frontiers in oncology
Published: December 15, 2022
Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer.
Journal: Cancers
Published: June 24, 2020
A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection.
Journal: Journal of translational medicine
Published: January 24, 2020
A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer.
Journal: Breast (Edinburgh, Scotland)
Published: September 21, 2018
Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer.
Journal: Molecular carcinogenesis
Published: April 09, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Journal: Human mutation
Published: October 30, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026